PLx Pharma Inc.
PLx Pharma Inc. (PLXP) Revenue
Annual & quarterly revenue history · segment & region breakdown
PLXP · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsPLx Pharma Inc. trailing twelve-month (TTM) revenue is $0.00B, an increase of 26873.38% year-over-year from $0.01B in FY2021.
Revenue trend
2021 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2021-12-31 | $0.01B | +$0.01B | +26873.38% |
| 2020-12-31 | $0.00B | -$0.00B | -94.62% |
| 2019-12-31 | $0.00B | -$0.00B | -24.92% |
| 2018-12-31 | $0.00B | -$0.00B | -3.28% |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | +$0.00B | — |
| 2015-12-31 | $0.00B | +$0.00B | — |
| 2014-12-31 | $0.00B | +$0.00B | — |
| 2013-12-31 | $0.00B | +$0.00B | — |
| 2012-12-31 | $0.00B | — | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income PLx Pharma Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
PLx Pharma Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from PLx Pharma Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PLXP revenue · 4 questionsPLXP's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 26873.38% year-over-year from $0.01B in FY2021.
▸ Source: FMP · PLx Pharma Inc. SEC filings · GAAP · PLx Pharma Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026